Aveanna Healthcare Holdings Inc. (AVAH)
| Market Cap | 1.47B +68.9% |
| Revenue (ttm) | 2.43B +20.2% |
| Net Income | 225.03M |
| EPS | 1.05 |
| Shares Out | 217.51M |
| PE Ratio | 6.45 |
| Forward PE | 10.82 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,636,806 |
| Open | 6.73 |
| Previous Close | 6.82 |
| Day's Range | 6.47 - 7.02 |
| 52-Week Range | 3.73 - 10.32 |
| Beta | 1.93 |
| Analysts | Buy |
| Price Target | 9.75 (+44.02%) |
| Earnings Date | May 14, 2026 |
About AVAH
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for AVAH stock is "Buy." The 12-month stock price target is $9.75, which is an increase of 44.02% from the latest price.
News
Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference
ATLANTA, May 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the William Blair 46th Annual Growth Stock Co...
Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays 30th Annual Leveraged Finance ...
Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call
ATLANTA, April 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open o...
Aveanna price target lowered to $8 from $9 at Truist
Truist analyst David MacDonald lowered the firm’s price target on Aveanna (AVAH) to $8 from $9 and keeps a Hold rating on the shares as part of a broader research…
Aveanna price target lowered to $9.50 from $11 at Barclays
Barclays lowered the firm’s price target on Aveanna (AVAH) to $9.50 from $11 and keeps an Overweight rating on the shares. The firm revised models in the healthcare facilities and…
Aveanna price target lowered to $9 from $11 at RBC Capital
RBC Capital lowered the firm’s price target on Aveanna (AVAH) to $9 from $11 and keeps a Sector Perform rating on the shares. Despite solid Q4 results and maintained guidance,…
Aveanna upgraded to Strong Buy from Outperform at Raymond James
Raymond James upgraded Aveanna (AVAH) to Strong Buy from Outperform with an unchanged price target of $13. The firm views the current valuation as “a discount to precedent transactions” with…
Aveanna price target lowered to $10 from $11 at BMO Capital
BMO Capital analyst Sean Dodge lowered the firm’s price target on Aveanna (AVAH) to $10 from $11 and keeps an Outperform rating on the shares. The company’s Q4 results were…
Aveanna price target lowered to $9 from $10 at Truist
Truist lowered the firm’s price target on Aveanna (AVAH) to $9 from $10 and keeps a Hold rating on the shares. The company reported a strong Q4, consistent with its…
Aveanna Healthcare Holdings Earnings Call Transcript: Q4 2025
Q4 and full year 2025 saw strong double-digit revenue and EBITDA growth, driven by improved rates, volumes, and cost efficiencies. 2026 guidance anticipates continued organic growth, further expansion of preferred payer agreements, and the accretive Family First acquisition, with stable margins and robust cash flow expected.
Aveanna sees FY26 revenue $2.54B-$2.56B, consensus $2.56B
Matt Buckhalter, Chief Financial Officer, commented, “2025 was a monumental year for Aveanna (AVAH). Our team delivered exceptional performance across the business, generating annual revenue growth of...
Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
ATLANTA, March 19, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient...
Aveanna announces agreement to acquire Family First Holding
Aveanna (AVAH) Healthcare announced that it has entered into an agreement to acquire Family First Holding. “I am excited to welcome the entire Family First Homecare team to Aveanna,” said…
Aveanna Healthcare Holdings Announces Agreement to Acquire Family First Homecare
ATLANTA, March 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient...
Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the...
Aveanna's Heartways Program Receives CHAP Disease Program Certification
ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (N...
Aveanna price target raised to $11 from $9 at Barclays
Barclays raised the firm’s price target on Aveanna (AVAH) to $11 from $9 and keeps an Overweight rating on the shares. The firm upped estimates post the company’s Q4 preannouncement.
Aveanna price target raised to $11 from $10 at RBC Capital
RBC Capital raised the firm’s price target on Aveanna (AVAH) to $11 from $10 and keeps a Sector Perform rating on the shares. At an industry event yesterday, the company…
Aveanna price target raised to $10 from $9.50 at UBS
UBS analyst AJ Rice raised the firm’s price target on Aveanna (AVAH) to $10 from $9.50 and keeps a Neutral rating on the shares.
Aveanna Healthcare Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference
Year three of strategic transformation delivered strong growth, margin expansion, and operational improvements, with 2025 guidance raised and 2026 outlook projecting continued organic and M&A-driven growth. Preferred payer strategies, cost efficiencies, and technology investments underpin momentum.
Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient ...
Aveanna Healthcare Holdings Transcript: Bank of America Home Care Conference
A leading home care provider outlined its 2025-2027 strategy, emphasizing scale, preferred payer partnerships, and disciplined M&A to drive double-digit revenue growth. Recent acquisitions, strong liquidity, and operational efficiencies support its outlook, despite a moderating rate environment.
Aveanna initiated with an Outperform at William Blair
William Blair analyst Jared Haase initiated coverage of Aveanna (AVAH) with an Outperform rating. Preferred payers are producing a more respectable growth algorithm, the analyst tells investors in a r...
Aveanna to Participate at the BofA Securities Home Care Conference
ATLANTA, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the BofA Securities Home Care Conference vir...
Aveanna initiated with an Outperform at BMO Capital
BMO Capital initiated coverage of Aveanna (AVAH) with an Outperform rating and $11 price target Shares are up about 130% since early August on strong Q2 and Q3 results fueled…